» Articles » PMID: 39610533

Alpha-glucosidase and α-amylase Inhibitory Activity of Desf. Gall Extracts and Identification of Putative Bioactives Using a Combined UPLC Fingerprinting and Molecular Docking Approach

Overview
Specialty Endocrinology
Date 2024 Nov 29
PMID 39610533
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Desf. (Anacardiaceae) is traditionally used in Mediterranean medicine, with previous studies showing antidiabetic potential in its fruits and leaves. This study evaluates the antidiabetic activity of galls (PAG) extracts using in vitro, chemometric, and in silico approaches.

Method: The antidiabetic activity of the samples were studied by measuring their half-maximal inhibitory concentrations (ICs) concentrations according to the in vitro enzyme inhibition assays and modelled as a function of the LC fingerprints using the partial least squares technique. Crystal structures of the human pancreatic α-amylase (HPA) and the α-glucosidase homologue isomaltase were obtained from the Protein Data Bank website (http://www.rcsb.org/pdb). Docking simulations and calculations were carried out using AutoDock Vina.

Results: PAG extracts inhibited HPA (ICs ranging from 1.85 to 2.92 mg/mL) and α-glucosidase (ICs ranging from 34 to 49 µg/mL) activities, with galls collected from male plants showing higher activity than those from female plants. UPLC fingerprinting, linked to chemometric analysis using a partial least squares regression model, putatively identified five compounds (quinic acid, methyl gallate, digalloyl quinic acid, methyl digallate, and valoneic acid dilactone) responsible for this antidiabetic effect. Molecular docking using AutoDock Vina revealed that the identified compounds interacted with key amino acid residues of HPA and α-glucosidase.

Conclusions: By employing UPLC fingerprinting combined with chemometric analysis and molecular docking simulations, quinic acid and digalloyl quinic acid were identified from gall extract as the most promising ligands for further investigation into their antidiabetic potential.

Graphical Abstract:

References
1.
Lascar N, Brown J, Pattison H, Barnett A, Bailey C, Bellary S . Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2017; 6(1):69-80. DOI: 10.1016/S2213-8587(17)30186-9. View

2.
Alam S, Sarker M, Sultana T, Chowdhury M, Rashid M, Chaity N . Antidiabetic Phytochemicals From Medicinal Plants: Prospective Candidates for New Drug Discovery and Development. Front Endocrinol (Lausanne). 2022; 13:800714. PMC: 8907382. DOI: 10.3389/fendo.2022.800714. View

3.
Gaonkar V, Hullatti K . Indian Traditional medicinal plants as a source of potent Anti-diabetic agents: A Review. J Diabetes Metab Disord. 2021; 19(2):1895-1908. PMC: 7843902. DOI: 10.1007/s40200-020-00628-8. View

4.
Rydberg E, Li C, Maurus R, Overall C, Brayer G, Withers S . Mechanistic analyses of catalysis in human pancreatic alpha-amylase: detailed kinetic and structural studies of mutants of three conserved carboxylic acids. Biochemistry. 2002; 41(13):4492-502. DOI: 10.1021/bi011821z. View

5.
Ahmed Z, Mohamed Y, Johan V, Dejaegher B, Demeyer K, Vander Heyden Y . Defining a standardized methodology for the determination of the antioxidant capacity: case study of Pistacia atlantica leaves. Analyst. 2019; 145(2):557-571. DOI: 10.1039/c9an01643k. View